FPS1 (iron death inhibition protein 1) is a human flavoprotein that inhibits ferroptosis by regenerating ubiquinone (CoQ10) via NAD(P)H-dependent reduction of lipid peroxidation radicals . Antibodies targeting FPS1 are critical tools for studying its role in cellular iron homeostasis, cancer biology, and therapeutic targeting . These antibodies enable researchers to detect FPS1 expression, localize the protein in tissues, and analyze its interactions in pathways such as ferroptosis suppression .
Antibody characterization is critical to ensure specificity and reproducibility. For example:
CSB-RA029525A0HU: Demonstrated specificity in flow cytometry using FITC-conjugated secondary antibodies, with clear distinction from control IgG .
16129-1-AP: Validated via Western blot (39–41 kDa band) and immunohistochemistry in human tissues .
Challenges in antibody validation, such as batch variability and off-target binding, underscore the importance of rigorous testing . Initiatives like the EU Affinomics program emphasize standardized characterization across applications (e.g., WB, IHC) to mitigate these issues .
FPS1 antibodies have been utilized to:
Study ferroptosis mechanisms: Detect FPS1 expression in cancer cells to explore its role in CoQ10-mediated lipid peroxidation suppression .
Therapeutic development: Screen for compounds that synergize with GPX4 inhibitors to induce ferroptosis in tumors .
Protein localization: Map FPS1 distribution in human tissues using IHC .
Ferroptosis regulation: FPS1 operates independently of glutathione, making it a unique therapeutic target .
Structural insights: Mutational studies using antibodies have identified critical cysteine residues in FPS1 required for its redox activity .
Cross-species reactivity: Some antibodies (e.g., CSB-PA008563GA01HU) recognize orthologs in mice and rats, enabling translational studies .
While FPS1 antibodies are indispensable, limitations persist:
KEGG: sce:YLL043W
STRING: 4932.YLL043W
FPS1 is a glycerol channel protein in yeast that plays a crucial role in regulating intracellular glycerol levels during osmotic stress responses. It functions as a regulated aquaglyceroporin that can rapidly open or close in response to environmental conditions. The importance of FPS1 in research stems from its central role in osmotic adaptation, where it prevents excessive glycerol accumulation under normal conditions and facilitates glycerol retention during hyperosmotic stress. Studies have shown that FPS1 channel function is tightly regulated by phosphorylation events, particularly through kinases like Ypk1, which can promote channel opening when specific serine residues are phosphorylated . Additionally, FPS1 channel activity is modulated by positive regulators such as Rgc1 and Rgc2, whose absence leads to severely impaired glycerol efflux despite elevated FPS1 protein levels . This complex regulation makes FPS1 an excellent model for studying post-translational modification, protein-protein interactions, and membrane channel dynamics in cellular stress responses.
Researchers typically use several types of antibodies to study FPS1, each suited for specific applications:
Monoclonal antibodies: These provide high specificity for a single epitope on FPS1, reducing background noise in techniques like Western blotting and immunofluorescence.
Polyclonal antibodies: These recognize multiple epitopes on FPS1, enhancing detection sensitivity, particularly useful for proteins with low expression levels.
Phospho-specific antibodies: Similar to phospho-specific antibodies for other proteins like Profilin 1 (phospho S138) , these detect specifically phosphorylated forms of FPS1, such as those modified by Ypk1 at key regulatory sites (e.g., S570). These antibodies are crucial for studying the phosphorylation-dependent regulation of FPS1 channel activity.
Epitope-tagged FPS1 detection antibodies: Many studies use epitope tags (FLAG, myc, HA) fused to FPS1, with corresponding highly specific antibodies. Studies have successfully employed FLAG-tagged FPS1 to monitor protein levels and phosphorylation states under various conditions .
When selecting an FPS1 antibody, researchers should consider the specific application, target epitope accessibility, and whether native or denatured protein conformations will be studied.
Validating FPS1 antibody specificity is crucial for experimental reliability. A comprehensive validation approach should include:
Western blot analysis with proper controls:
Compare wild-type samples with FPS1 deletion mutants (fps1Δ)
Include positive controls with overexpressed FPS1
Test for cross-reactivity with related proteins
Epitope competition assays: If the epitope sequence is known, pre-incubate the antibody with excess peptide antigen before immunodetection. Signal reduction confirms specificity.
Phospho-antibody validation: For phospho-specific FPS1 antibodies, validate using:
Multiple detection methods: Confirm specificity across techniques (Western blot, immunoprecipitation, immunofluorescence).
Quantitative assessments: When studying FPS1 protein levels in response to mutations or treatments, quantify signals relative to loading controls and validate with multiple antibodies when possible .
Data from studies using epitope-tagged FPS1 show that antibody specificity can be rigorously validated using controls like the rgc1/2Δ mutant, which exhibits approximately 10-fold higher FPS1 protein levels compared to wild-type strains .
Optimal sample preparation for FPS1 antibody experiments depends on the specific application but should follow these general principles:
For Western blotting:
Harvest yeast cells during mid-logarithmic growth phase
Perform rapid lysis to prevent protein degradation (glass bead disruption in cold buffer containing protease inhibitors)
Include phosphatase inhibitors when studying phosphorylated FPS1
For membrane protein extraction, use detergent-containing buffers (e.g., 1% Triton X-100)
Separate proteins using 8-10% SDS-PAGE gels for optimal resolution
For immunoprecipitation:
For immunofluorescence:
Fix cells using paraformaldehyde followed by spheroplasting
Permeabilize with appropriate detergents (0.1% Triton X-100)
Block thoroughly to reduce background signal
For phosphorylation studies:
Research data suggests that when studying FPS1 protein levels, experimental conditions significantly impact results. For instance, expression from native promoters versus heterologous promoters can yield different fold changes in protein levels between mutant and wild-type strains .
FPS1 channel activity is critically regulated by phosphorylation, and antibodies offer powerful tools for investigating these regulatory mechanisms:
Phospho-specific antibodies for direct detection:
Develop antibodies that specifically recognize phosphorylated regulatory sites (e.g., S570) on FPS1
Monitor phosphorylation kinetics during osmotic stress responses
Compare phosphorylation levels between wild-type and kinase mutant strains (e.g., ypk1Δ)
Phos-tag gel electrophoresis coupled with FPS1 antibodies:
Use Phos-tag SDS-PAGE to separate phosphorylated FPS1 forms
Detect with general FPS1 antibodies to visualize mobility shifts
Quantify the ratio of phosphorylated to non-phosphorylated forms under different conditions
Correlating phosphorylation with channel function:
The importance of phosphorylation is highlighted by research showing that Ypk1-mediated phosphorylation promotes channel opening, while its absence (as in FPS1 3A mutants) keeps the channel closed, leading to approximately 2-fold higher intracellular glycerol concentrations . Additionally, researchers have observed that hyperosmotic stress rapidly reduces Ypk1-dependent FPS1 phosphorylation, highlighting the dynamic regulation of channel activity.
| FPS1 Phosphorylation State | Channel State | Intracellular Glycerol | Arsenite Resistance |
|---|---|---|---|
| Phosphorylated (wild-type) | More open | Lower | Sensitive |
| Non-phosphorylated (FPS1 3A) | More closed | ~2x higher | Resistant |
| Single-site mutants | Partially open | Intermediate | Intermediate resistance |
Studying FPS1 interactions with regulatory proteins like Rgc1/Rgc2 requires specialized antibody-based approaches:
Co-immunoprecipitation (Co-IP):
Proximity ligation assay (PLA):
Use primary antibodies against FPS1 and suspected interaction partner
Secondary antibodies with conjugated oligonucleotides enable fluorescent signal only if proteins are in close proximity
Particularly useful for visualizing interactions in situ
Bimolecular fluorescence complementation (BiFC):
Express FPS1 and interaction partner each fused to complementary fragments of fluorescent protein
Detect reconstituted fluorescence using antibodies against the tag or direct fluorescence imaging
Pull-down assays with phosphorylation state consideration:
Compare interactions between phosphorylated and non-phosphorylated FPS1
Use phospho-mutants (e.g., FPS1 3A) to assess phosphorylation-dependent interactions
Research has demonstrated that the interaction between FPS1 and its regulatory proteins is affected by phosphorylation state. For example, studies have shown that Rgc2-HA can be co-immunoprecipitated with FLAG-tagged FPS1, allowing researchers to compare binding efficiency between wild-type FPS1 and phospho-mutants like FPS1 3A .
FPS1 localization dynamics during osmotic stress can be studied using antibody-based techniques:
Immunofluorescence microscopy:
Fix cells at various timepoints after osmotic shock
Use primary FPS1 antibodies followed by fluorescent secondary antibodies
Co-stain with markers for plasma membrane, endocytic vesicles, and vacuoles
Quantify relative distribution across cellular compartments
Subcellular fractionation with immunoblotting:
Separate cellular components by differential centrifugation
Probe fractions with FPS1 antibodies
Include fraction-specific markers (e.g., Pma1 for plasma membrane)
Quantify redistribution following osmotic stress
Surface biotinylation assays:
Label surface proteins with membrane-impermeable biotinylation reagent
Immunoprecipitate FPS1 or pull down biotinylated proteins
Quantify surface-exposed FPS1 before and after osmotic stress
Live-cell imaging with epitope-tagged FPS1:
Use fluorescent anti-tag antibody fragments for live-cell applications
Monitor real-time changes in localization during osmotic shifts
Multiple bands in FPS1 Western blots can result from several factors:
Post-translational modifications:
Protein degradation:
FPS1 may undergo specific proteolytic processing
Sample preparation without sufficient protease inhibitors can result in degradation products
Alternative isoforms:
Expression from alternative start sites
Splice variants (in higher eukaryotes with FPS1-like proteins)
Cross-reactivity:
Antibody binding to related proteins with similar epitopes
Non-specific binding to abundant proteins
To distinguish between these possibilities:
For phosphorylation: Treat samples with phosphatase and observe band collapse
For degradation: Compare fresh samples to aged samples and include protease inhibitor controls
For alternative isoforms: Use antibodies targeting different regions of FPS1
For cross-reactivity: Include fps1Δ controls to identify non-specific bands
Research has shown that FPS1 phosphorylation status can significantly affect its migration pattern in SDS-PAGE, particularly when using Phos-tag gels that enhance separation of phosphorylated forms . Comparing wild-type with phospho-mutants like FPS1 3A can help identify bands representing differently phosphorylated species.
Robust experimental design requires appropriate controls to validate FPS1 antibody results:
Genetic controls:
Treatment controls:
Technical controls:
Loading controls (housekeeping proteins)
Non-specific IgG for immunoprecipitation background
Blocking peptide competition for specificity validation
Secondary antibody-only controls for immunofluorescence
Quantification controls:
Standard curves with recombinant protein
Dilution series to ensure linearity of detection
The importance of proper controls is demonstrated in studies showing that FPS1 protein levels can increase approximately 10-fold in rgc1/2Δ mutants compared to wild-type strains, but this increase is dependent on glycerol production, as it is not observed in rgc1/2Δ gpd1/2Δ quadruple mutants . This highlights the need for multiple genetic controls when interpreting changes in FPS1 expression or modification.
Optimizing antibody dilutions is crucial for balancing signal strength with background reduction:
Western blotting optimization:
Immunofluorescence optimization:
Typically requires higher antibody concentrations than Western blotting
Test range from 1:50 to 1:500 for primary antibodies
Include blocking peptide controls at each dilution to assess specificity
Immunoprecipitation optimization:
Determine minimum antibody amount needed for efficient pull-down
Typically 1-5 μg antibody per mg of total protein
Test different antibody-to-bead ratios
Quantitative considerations:
Ensure signal is within linear range of detection
For comparative studies, maintain identical antibody dilutions across all samples
Validate with standard curves using recombinant protein
| Application | Typical Starting Dilution Range | Optimization Method | Key Considerations |
|---|---|---|---|
| Western Blot | 1:1000 - 1:5000 | Dilution series | Signal-to-noise ratio |
| Immunofluorescence | 1:50 - 1:500 | Titration with controls | Background fluorescence |
| Flow Cytometry | 1:50 - 1:200 | Comparison with isotype control | Signal separation |
| ELISA | 1:1000 - 1:10000 | Checkerboard titration | Detection limit |
Optimization should be performed for each new antibody lot and experimental setup, as variables like protein expression levels can significantly impact optimal dilutions.
The emergence of AI-designed antibodies represents a transformative opportunity for FPS1 research:
Enhanced epitope targeting precision:
AI platforms like RFdiffusion can design antibodies with higher specificity for particular FPS1 epitopes
This could enable development of antibodies that distinguish between closely related phosphorylation states
More precise targeting of conformational epitopes associated with open/closed channel states
Improved antibody characteristics:
Novel detection capabilities:
Design of antibodies specifically targeting FPS1 in complex with regulatory proteins
Development of antibodies that selectively recognize disease-relevant conformational states
Creation of conformation-sensitive antibodies to monitor channel activity states
Accelerated research timelines:
Recent advancements in AI-driven antibody design demonstrate that platforms like RFdiffusion can now generate complete and human-like antibodies (scFvs) with specific binding properties . These technologies could revolutionize FPS1 research by enabling the rapid development of highly specific tools for studying this complex channel protein.
Several cutting-edge techniques are poised to transform FPS1 antibody applications:
Single-molecule imaging with antibody-based probes:
Super-resolution microscopy with antibody-conjugated fluorophores
Tracking individual FPS1 molecules in living cells
Monitoring real-time conformational changes during channel gating
Mass cytometry (CyTOF) for multiplexed detection:
Simultaneous measurement of multiple phosphorylation sites on FPS1
Correlation with other signaling pathways and regulatory proteins
Single-cell analysis of FPS1 regulation in heterogeneous populations
Antibody-based biosensors:
FRET-based sensors using FPS1 antibodies to monitor conformational changes
Development of antibody-based reporters for FPS1 activity in live cells
Integration with microfluidics for high-throughput screening
Spatial proteomics with antibody-based detection:
Combining FPS1 antibodies with spatial transcriptomics
Mapping FPS1 distribution and modification state across cellular compartments
Correlating with local glycerol concentrations and osmotic responses
Nanobody technology:
Development of small single-domain antibodies against FPS1
Enhanced access to sterically hindered epitopes
Potential for intracellular expression to monitor FPS1 in living cells
The application of RFdiffusion and similar AI technologies, which have already been successfully applied to generate antibodies against targets like influenza hemagglutinin and bacterial toxins , could be extended to develop novel antibody-based tools specifically optimized for FPS1 research.